The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of DKN-01, an anti-DKK1 antibody, in combination with gemcitabine (G) and cisplatin (C) in patients (pts) with advanced biliary cancer.
 
Jennifer Rachel Eads
Consulting or Advisory Role - Novartis; Oxigene; Portola Pharmaceuticals; Saatchi Wellness
Research Funding - AstraZeneca; Bayer; HealthCare Pharmaceuticals; Merck; Novartis
Travel, Accommodations, Expenses - Amgen
 
Lipika Goyal
No Relationships to Disclose
 
Stacey Stein
No Relationships to Disclose
 
Anthony B. El-Khoueiry
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche
Speakers' Bureau - Merrimack
Research Funding - Astex Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline
 
Gulam A Manji
No Relationships to Disclose
 
Thomas Adam Abrams
Honoraria - BTG; Cardinal Health; Celgene
Consulting or Advisory Role - Aduro Biotech
Research Funding - Celgene
Travel, Accommodations, Expenses - BTG; Cardinal Health; Celgene
 
Steven B. Landau
Employment - Leap Therapeutics; Shape Pharmaceuticals; Tensha Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics; Shape Pharmaceuticals; Tensha Therapeutics
 
Cynthia A. Sirard
Employment - Leap Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics
Patents, Royalties, Other Intellectual Property - Leap Therapeutics